Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.53 USD | -0.84% | -8.31% | -34.02% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
Financials (USD)
Sales 2024 * | 112M | Sales 2025 * | 124M | Capitalization | 153M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 3M | EV / Sales 2024 * | 1.37 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
-44.1
x | P/E ratio 2025 * |
47.1
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | -0.84% | ||
1 week | -8.31% | ||
Current month | -7.59% | ||
1 month | -18.76% | ||
3 months | -25.37% | ||
6 months | -11.75% | ||
Current year | -34.02% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.53 | -0.84% | 69,177 |
24-05-09 | 3.56 | -3.26% | 115,411 |
24-05-08 | 3.68 | -1.87% | 85,633 |
24-05-07 | 3.75 | -4.34% | 130,699 |
24-05-06 | 3.92 | +1.82% | 116,616 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.02% | 153M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- HBIO Stock